Skip to main content
Smart Investors Daily
McKesson Corporation logo

NYSE · MCK

McKesson Corporation

Healthcare · Medical - Distribution

$980.88

Up+$13.70 (+1.40%)

Updated Oct 30, 2026, 10:51 PM

SID Score

6.9/10

Composite research score

Smart Money

57/100

Neutral

Market cap
101.96B
P/E ratio
32.2
Dividend yield
0.31%
52-week range
$723.68 – $1,030.27
Volume
721.49K
Avg. volume
896.08K

Price performance · MCK

MCK price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

MCK closed at $980.88 after 21 trading sessions, up 9.13% for the selected period.

Last close
$980.88
Period change
+9.13%
Period low
$898.82
Period high
$1,030.12
Daily close
View OHLC price history
MCK OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$975.00$982.70$964.77$980.88721.49K
Oct 28, 2026$955.95$970.925$954.05$960.56764.14K
Oct 27, 2026$989.04$992.8225$966.49$967.02587.07K
Oct 26, 2026$1,001.39$1,008.60$988.03$992.87508.22K
Oct 23, 2026$1,010.32$1,012.495$997.02$1,000.77628.97K
Oct 22, 2026$1,025.62$1,025.62$1,006.07$1,012.34629.49K
Oct 21, 2026$1,020.93$1,030.00$1,005.42$1,015.50772.09K
Oct 20, 2026$1,021.14$1,030.27$1,013.925$1,030.12789.41K
Oct 19, 2026$995.72$1,012.58$977.8888$1,010.43757.17K
Oct 16, 2026$1,012.20$1,014.99$999.27$1,004.84621.36K
Oct 15, 2026$995.80$1,003.21$988.61$998.64728.67K
Oct 14, 2026$968.07$979.82$965.045$976.57769.08K
Oct 13, 2026$963.42$969.477$954.18$961.88743.64K
Oct 12, 2026$949.95$956.24$936.7742$955.76646.98K
Oct 9, 2026$927.56$943.97$925.00$938.84482.91K
Oct 8, 2026$906.65$938.51$906.65$930.25715.66K
Oct 7, 2026$924.21$933.99$908.49$910.33794.46K
Oct 6, 2026$921.00$928.46$914.225$921.67680.46K
Oct 5, 2026$905.22$922.46$900.72$915.45697.63K
Oct 2, 2026$899.02$905.55$881.40$902.28777.05K
Oct 1, 2026$886.47$924.21$881.34$898.821.21M

Latest MCK news

The latest Smart Investors Daily articles mentioning MCK.

MCK research

Overview

Company profile and research snapshot.

Company profile

McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$910.40
Implied upside
—
Analysts
14
MCK recent ratings
DateFirmRatingTarget
Oct 20, 2026MizuhoNeutral—
Oct 16, 2026UBSBuy—
Oct 7, 2026Leerink PartnersOutperform—
Sep 14, 2026RBC CapitalSector Perform—
Aug 19, 2026BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 21, 2026

McKesson Corporation Declares Quarterly Dividend

IRVING, Texas, October 21, 2026--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 94 cents per share of common stock. The dividend will be payable on January 4, 2027, to shareholders of record on December 1, 2026.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.